EKF Diagnostics Holdings Plc is a vitro diagnostics company, which engages in the designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2002-06-05. The firm is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.
Follow-Up Questions
What is the price performance of EKDHF stock?
The current price of EKDHF is $0.4237, it has decreased 0% in the last trading day.
What are the primary business themes or industries for EKF Diagnostics Holdings PLC?
EKF Diagnostics Holdings PLC belongs to Health Care industry and the sector is Health Care
What is EKF Diagnostics Holdings PLC market cap?
EKF Diagnostics Holdings PLC's current market cap is $190.2M
Is EKF Diagnostics Holdings PLC a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for EKF Diagnostics Holdings PLC, including 4 strong buy, 6 buy, 1 hold, 0 sell, and 4 strong sell
